Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saginaw, MI
NPI
1942430574
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 Houghton Ave
Saginaw, MI, 48602
Phone (989) 746-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
722 services
Medicare patients, 2024
216
Average age 68
Drug cost, 2024
$1.5M
2,720 prescriptions
Company payments, 2023
$82.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vivek Variar was code 99214 (office e&m - established), 222 times for 131 patients. In total Vivek Variar billed 722 services in 18 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 222 | 131 | $83.71 | $19K |
| 83036 Blood Count | Office | 156 | 87 | $9.09 | $1,418 |
| 95251 Test - Miscellaneous | Office | 147 | 77 | $23.55 | $3,461 |
| 99213 Office E&M - Established | Office | 89 | 79 | $61.32 | $5,457 |
| 99204 Office E&M - New | Office | 25 | 25 | $97.57 | $2,439 |
By year: 2022 $43K for 832 services; 2023 $34K for 654 services; 2024 $36K for 722 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 156 | 87 | $9.09 | $1,418 |
Medicare prescription drug claims, 2024
In 2024, the drug Vivek Variar prescribed most often to Medicare patients was Levothyroxine Sodium, with 369 prescriptions and refills. In total Vivek Variar wrote 2,720 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 369 | 1,000 | 108 | $5,617 |
| Mounjaro Tirzepatide | 182 | 231 | 38 | $237K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 170 | 453 | 73 | $32K |
| Methimazole Generic | 129 | 366 | 41 | $2,274 |
| Trulicity Dulaglutide | 121 | 160 | 24 | $152K |
| Ozempic Semaglutide | 117 | 212 | 35 | $197K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 102 | 160 | 21 | $103K |
| Novolog Flexpen Insulin Aspart | 83 | 209 | 45 | $34K |
| Humalog Kwikpen U-100 Insulin Lispro | 78 | 212 | 38 | $48K |
| Glipizide Generic | 78 | 224 | 35 | $903 |
| Novolog Insulin Aspart | 62 | 165 | 23 | $23K |
| Jardiance Empagliflozin | 59 | 126 | 16 | $70K |
| Metformin Hcl Generic | 47 | 139 | 18 | $673 |
| Metformin Hcl Er Metformin Hcl | 47 | 125 | 17 | $578 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 45 | 118 | 17 | $23K |
Brand drugs: 1,495 claims; generic drugs: 851 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Vivek Variar $82.18 ($82.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $82.18.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $82.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.